ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » South Dakota » Rheumatology

Top Rheumatology Prescribers in South Dakota

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ROBERT WISCO MD

Rheumatology

8,441

$685K

655
469 are 65+

4%
patients receiving schedule two controlled substances

15%
patients receiving schedule three controlled substances

2%
prescriptions for patients 65+ for potentially dangerous drugs

23%
prescriptions for brand name drugs

$81
Average prescription price

JOSEPH FANCIULLO MD

Rheumatology

3,498

$575K

361
283 are 65+

0%
patients receiving schedule two controlled substances

5%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

28%
prescriptions for brand name drugs

$164
Average prescription price

KARA PETERSEN M.D.

Rheumatology

3,113

$400K

280
231 are 65+

0%
patients receiving schedule two controlled substances

10%
patients receiving schedule three controlled substances

1%
prescriptions for patients 65+ for potentially dangerous drugs

27%
prescriptions for brand name drugs

$129
Average prescription price

RICARDO ALVILLAR M.D.

Rheumatology

2,836

$331K

292
154 are 65+

0%
patients receiving schedule two controlled substances

5%
patients receiving schedule three controlled substances

1%
prescriptions for patients 65+ for potentially dangerous drugs

23%
prescriptions for brand name drugs

$117
Average prescription price

GREGORY MUMM M.D.

Rheumatology

2,224

$222K

266
206 are 65+

0%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

29%
prescriptions for brand name drugs

$100
Average prescription price

CHRISTINE HALLIGAN MD

Rheumatology

1,949

$199K

189
153 are 65+

0%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

23%
prescriptions for brand name drugs

$102
Average prescription price

BRIAN FAY M.D.

Rheumatology

1,356

$87.6K

172
130 are 65+

0%
patients receiving schedule two controlled substances

8%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

21%
prescriptions for brand name drugs

$65
Average prescription price

DOMINIK SOKALSKI M.D.

Rheumatology

721

$135K

196
128 are 65+

0%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

26%
prescriptions for brand name drugs

$187
Average prescription price

BRIAN BOWERS DO

Rheumatology

679

$64.6K

115
99 are 65+

0%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

2%
prescriptions for patients 65+ for potentially dangerous drugs

24%
prescriptions for brand name drugs

$95
Average prescription price

LEANN BASSING M.D.

Rheumatology

231

$6,784

61
51 are 65+

0%
patients receiving schedule two controlled substances

0%
patients receiving schedule three controlled substances

0%
prescriptions for patients 65+ for potentially dangerous drugs

18%
prescriptions for brand name drugs

$29
Average prescription price

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank